AGP Picks
View all

American Financial Tribune: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on American Financial Tribune.

Press releases published on November 2, 2026

Krystal Biotech Announces Third Quarter 2026 Financial and Operating Results
Ceribell Expands Its Point-of-Care Brain Monitoring Platform with Commercial Launch of Delirium Monitoring Solution
Climb Bio to Present at Guggenheim 3rd Annual Healthcare Innovation Conference
Rapport Announces Closing of Public Offerings of Common Stock and Pre-Funded Warrants and Convertible Notes, Including Full Exercise of Underwriters’ Options to Purchase Additional Shares and Notes, as well as Concurrent Private Placement
Monte Rosa Therapeutics to Participate in Upcoming Investor Conferences
Ocular Therapeutix™ to Report Third Quarter 2026 Financial Results on November 9, 2026
Tilray Brands Announces Strategy to Strengthen Canadian Cannabis Operations and Drive Profitable Growth
Harrow Launches HarrowRx Platform
Lexeo Therapeutics to Present Multiple Oral and Poster Presentations at Key Scientific Conferences in November
Macerich Declares the Quarterly Dividend on Its Common Shares
FLUENT Corp. Announces Proposed Debt Settlement
POET Technologies Names Giovanni Pacelli CFO
WRAP Taps Former NYPD Chief Behind Narcan Rollout to Scale BolaWrap and Operationalize De-Escalation
SUNation Energy Announces Confidential Submission of Draft Registration Statement on Form S-4 in Connection with Proposed Merger with Suniva
Axsome Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update
 NorthStrive Acquisition Corp I Announces Business Combination with Nuclea Energy
Cipher Digital Provides Third Quarter 2026 Business Update
Tonix Pharmaceuticals Appoints George Lederman, Ph.D., as Executive Vice President of Strategy and Transformation
Tower Semiconductor Reports Third Quarter Record Results, Providing Record Fourth Quarter Guidance Resulting in 2026 $2 Billion Annual Revenue
Tiziana Announces Positive Topline Results from Phase 2a INFORM-MS Trial of Intranasal Foralumab in Non-Active Secondary Progressive Multiple Sclerosis

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

American Financial Tribune

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.